Should you buy Medibank (ASX: MPL) shares in July for the dividend?

Is Medibank a dividend buy today?
The post Should you buy Medibank (ASX: MPL) shares in July for the dividend? appeared first on The Motley Fool Australia. –

Should you consider the Medibank Private Ltd (ASX: MPL) share price in July 2021 for the dividend yield?

Private health insurance giant Medibank has amassed a reputation as a heavyweight ASX dividend share ever since its 2014 transition from government-owned entity to public company.

In fact, the company had been steadily ramping up its dividend payments until the coronavirus crisis came to our shores last year. From 2015 until 2019, Medibank increased its dividend payouts every single year like clockwork.

But Medibank was indeed forced to trim its payouts last year. In 2019, the company paid out three dividends. These consisted of a single interim payment of 5.7 cents per share, and a final and special dividend of 7.4 cents and 2.5 cents per share respectively.

What kind of dividends are Medibank shares offering today?

In 2020, Medibank kept its March interim dividend at 5.7 cents. However, it was forced to trim its September final dividend down to 6.3 cents per share.

In 2021 so far, the company has paid an interim dividend of 5.8 cents per share. That’s a slight bump to its last two interim dividends.

These dividend payments give Medibank shares a trailling yield of 3.64% on current pricing. That rises to 5.21% grossed-up with the company’s usual full franking.

It’s not yet certain what Medibank’s final dividend will look like when it gets delivered to shareholders’ bank accounts in September this year. But investment bank Goldman Sachs has a prediction.

Goldman estimates Medibank will pay out 12.6 cents per share in dividends for FY21, which means it is anticipating a final dividend of 6.8 cents per share. That would give Medibank shares a forward yield of 3.81% on current pricing.

Further, in some good news for those income investors who appreciate a steadily rising dividend, Goldman is predicting Medibank will be able to resume its pattern of annual dividend increases. It anticipates the company’s dividend will reach 13.3 cents per share by FY2023.

It’s worth noting that Goldman currently has a ‘neutral’ rating on the Medibank share price. With a 12-month price target of $3.34 a share, that’s just 0.9% above the share price Medibank closed at yesterday.

At this share price, Medibank has a market capitalisation of $9.14 billion, with a price-to-earnings (P/E) ratio of 25.34.

The post Should you buy Medibank (ASX: MPL) shares in July for the dividend? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank Private right now?

Before you consider Medibank Private, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

The Medibank (ASX:MPL) share price just hit a new 52-week high
Top brokers name 2 ASX dividend shares to buy today

Medibank Private (ASX:MPL) share price sets new 52-week high today
Medibank (ASX:MPL) share price up as customers get millions in support

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!